Modification of ocular and systemic absorption of timolol from ocular inserts by a buffering agent and a vasoconstrictor
- 5 November 1990
- journal article
- research article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 65 (1-2), 19-27
- https://doi.org/10.1016/0378-5173(90)90004-n
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Controlled drug delivery devices for experimental ocular studies with timolol 2. Ocular and systemic absorption in rabbitsInternational Journal of Pharmaceutics, 1990
- Drug release from monoisopropyl ester of poly(vinyl methyl ether-maleic anhydride) can be modified by basic salts in the polymer matrixJournal of Controlled Release, 1989
- Ophthalmic Epinephrine, Phenylephrine, and Pilocarpine Affect the Systemic Absorption of Ocularly Applied TimololJournal of Ocular Pharmacology and Therapeutics, 1989
- Application Site Dependent Ocular Absorption of TimololJournal of Ocular Pharmacology and Therapeutics, 1988
- Effects of Eyelid Closure and Nasolacrimal Duct Occlusion on the Systemic Absorption of Ocular Timolol in Human SubjectsJournal of Ocular Pharmacology and Therapeutics, 1986
- Pilocarpine release from matrices of alkyl half-esters of poly(vinyl methyl ether/maleic anhydride)International Journal of Pharmaceutics, 1985
- Systemic absorption of ocular pilocarpine is modified by polymer matricesInternational Journal of Pharmaceutics, 1985
- Lack of Metabolism of Timolol by Ocular TissuesJournal of Ocular Pharmacology and Therapeutics, 1985
- Controlled Drug Release by Polymer Dissolution II: Enzyme-Mediated Delivery DeviceJournal of Pharmaceutical Sciences, 1979
- Controlled drug release by polymer dissolution. I. Partial esters of maleic anhydride copolymers—properties and theoryJournal of Applied Polymer Science, 1978